Pharmaceutical composition comprising factor VII...

Details Pharmaceutical composition comprising factor VII... Pharmaceutical composition comprising factor VII...

2007-11-06

2007-11-06

Tsang, Cecilia (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S018700, C424S094100

Reexamination Certificate

active

10290814

ABSTRACT:
The present invention relates to a composition comprising factor VII or a factor VII-related polypeptide, and TAFI or a TAFI-related polypeptide, and the use thereof for treating bleeding episodes.

REFERENCES:
patent: 5206161 (1993-04-01), Drayna et al.
patent: 5364934 (1994-11-01), Drayna et al.
patent: 5474901 (1995-12-01), Drayna et al.
patent: 5593674 (1997-01-01), Drayna et al.
patent: 5672496 (1997-09-01), Fayerman et al.
patent: 5866122 (1999-02-01), Turecek et al.
patent: 6808927 (2004-10-01), Greenfield et al.
patent: 6825323 (2004-11-01), Hess
patent: 6838432 (2005-01-01), Taylor et al.
patent: 7015193 (2006-03-01), Butenas et al.
patent: 2002/0177560 (2002-11-01), Greenfield et al.
patent: 2003/0040480 (2003-02-01), Rojkjaer
patent: 2003/0054018 (2003-03-01), Hedner
patent: 2003/0073638 (2003-04-01), Kjalke
patent: 2003/0092627 (2003-05-01), Petersen et al.
patent: 2003/0109446 (2003-06-01), Rojkjaer
patent: 2003/0118580 (2003-06-01), Rojkjaer
patent: 2003/0118582 (2003-06-01), Rojkjaer
patent: 2003/0119723 (2003-06-01), Rojkjaer
patent: 2003/0119741 (2003-06-01), Rojkjaer
patent: 2003/0119743 (2003-06-01), Rojkjaer
patent: 2003/0124118 (2003-07-01), Rojkjaer
patent: 2003/0125256 (2003-07-01), Rojkjaer
patent: 2003/0199444 (2003-10-01), Knudsen
patent: 2003/0203845 (2003-10-01), Knudsen
patent: 2004/0006020 (2004-01-01), Rojkjaer
patent: 2004/0006021 (2004-01-01), Rojkjaer
patent: 2004/0258690 (2004-12-01), Rojkjaer
patent: 0082182 (1982-05-01), None
patent: 0225160 (1986-11-01), None
patent: WO93/06855 (1993-04-01), None
patent: WO98/35988 (1998-08-01), None
patent: WO98/58661 (1998-12-01), None
patent: WO 00/61727 (2000-10-01), None
patent: WO 00/61727 (2000-10-01), None
patent: WO 00/66717 (2000-11-01), None
patent: WO 01/83725 (2001-11-01), None
Bajzar et al., Blood, vol. 88, No. 6, pp. 2093-2100 (1996).
Eaton et al., The Journal of Biological Chemistry, vol. 266, No. 32, pp. 21833-21838 (1991).
Mosnier et al., Thrombosis and Haemostasis, vol. 86, pp. 1035-1039 (2001).
Nesheim et al., Thrombosis and Haemostasis, vol. 78, No. 1, pp. 386-391 (1997).
Wang et al., The Journal of Biological Chemistry, vol. 269, No. 22, pp. 15937-15944 (1994).
Roberts et al.,Seminars in Hematology, 41(1—Suppl 1):101-108 (2004).
NovoSeven® (Coagulation Factor VIIa (Recombinant)) US FDA Package.
Amaral et al.,Intensive Care Med., 30:1032-1040 (2004).
Zeerleder et al.,Chest, 128:2864-2875 (2005).

Affiliated with

Also associated with

Rating

Pharmaceutical composition comprising factor VII... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition comprising factor VII..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition comprising factor VII... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3835308